Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $617.8200 (-0.48%) ($611.7100 - $617.8200) on Tue. Feb. 8, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.54% (three month average) | RSI | 50 | Latest Price | $617.8200(-0.48%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.2% a day on average for past five trading days. | Weekly Trend | REGN advances 0.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(55%) DIA(40%) IWD(39%) XLV(39%) SPLV(37%) | Factors Impacting REGN price | REGN will decline at least -0.77% in a week (0% probabilities). VIXM(-18%) TBT(-10%) UUP(-8%) VXX(-3%) USO(-0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.77% (StdDev 1.54%) | Hourly BBV | -1.3 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $621.31(-0.56%) | 10 Day Moving Average | $616.52(0.21%) | 20 Day Moving Average | $616.76(0.17%) | To recent high | -7.9% | To recent low | 3.8% | Market Cap | $65.507b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |